Physician’s WeeklyMost Common Bacterial Coinfections Identified in Children With RSV

Nearly 1 in 3 children under 5 with RSV carries a concurrent bacterial pathogen. A 125-study systematic review found 28.9% pooled bacterial co-detection prevalence, with coinfected children facing an odds ratio of 31.3 for death and 26.9 for PICU admission compared to RSV-only cases.

Clinical Considerations

• Three pathogens dominate: Moraxella catarrhalis (7%), Haemophilus influenzae (5%), and Streptococcus pneumoniae as the most prevalent co-detected bacteria across more than 60 identified species
• Coinfection amplifies severity markers: fever, abnormal chest X-rays, elevated CRP, and distinct immunological profiles all appear at higher rates, alongside greater antibiotic use and healthcare resource utilization
• Geography and seasonality drive prevalence: rates are significantly higher in low- and middle-income countries, and seasonal sampling detected Pseudomonas aeruginosa in 11.7% of cases versus 1.5% during year-round surveillance
• Most bacteria localize to the respiratory tract: upper (43.6%) and lower (36.6%) airway samples account for the vast majority; bacteremia is rare (4.9%)

Practice Applications

• Use CRP and procalcitonin in combination with chest imaging and symptom algorithms before initiating antibiotics in RSV-positive children
• Avoid empiric antibiotic treatment based on RSV diagnosis alone; co-detection does not confirm pathogenic infection versus colonization
• Escalate monitoring rapidly in coinfected children; PICU admission odds are more than double those of RSV-only cases
• Monitor microbiome impact when initiating novel RSV therapeutics, as emerging interventions may alter bacterial coinfection risk profiles

More in Bacterial Infections